SSY Group Limited (HKG:2005)
Hong Kong · Delayed Price · Currency is HKD 2.695
+0.050 (1.89%)
Aug 27, 2026, 1:04 PM HKT
SSY Group Financials Overview
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,379 | 4,165 | 5,773 | 6,463 | 6,434 | 5,357 |
Revenue Growth | 5.12% | -27.85% | -10.67% | 0.45% | 20.11% | 25.72% |
Gross Profit Gross Profit Growth | 1,813 | 1,731 | 2,908 | 3,620 | 3,568 | 3,170 |
Operating Income Operating Income Growth | 669.96 | 595.52 | 1,363 | 1,638 | 1,422 | 1,006 |
Net Income Net Income Growth | 507.45 | 470.64 | 1,061 | 1,319 | 1,123 | 785.53 |
Earnings Per Share EPS Growth | 0.17 | 0.16 | 0.36 | 0.44 | 0.38 | 0.26 |
EPS Growth | 8.81% | -55.19% | -19.09% | 17.68% | 45.16% | 28.78% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Materials Medical Materials Growth | 377.42 | 405.07 | 387.45 | 350.84 | 356.62 |
Intravenous Infusion Solution and Others Intravenous Infusion Solution and Others Growth | 3,970 | 5,585 | 6,301 | 6,265 | 5,209 |
Inter-Segment Inter-Segment Growth | -182.24 | -216.91 | -225.82 | - | - |
Total Total Growth | 4,165 | 5,773 | 6,463 | 6,434 | 5,357 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,891 | 1,795 | 1,407 | 1,616 | 1,714 | 1,700 |
Total Debt Total Debt Growth | 4,049 | 4,015 | 3,640 | 3,374 | 3,209 | 3,108 |
Net Cash (Debt) Net Cash Growth | -2,158 | -2,219 | -2,232 | -1,758 | -1,495 | -1,408 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.74 | -0.76 | -0.75 | -0.59 | -0.50 | -0.46 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 635.04 | 491.03 | 925.75 | 733.69 | 695.63 |
Capital Expenditures CapEx Growth | - | -141.06 | -318.85 | -436.87 | -203.22 | -169.7 |
Free Cash Flow Free Cash Flow Growth | - | 493.98 | 172.18 | 488.87 | 530.47 | 525.93 |
Free Cash Flow Growth | - | 186.89% | -64.78% | -7.84% | 0.86% | 81.44% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 41.40% | 41.56% | 50.38% | 56.01% | 55.45% | 59.18% |
Operating Margin | 15.30% | 14.30% | 23.61% | 25.34% | 22.10% | 18.77% |
Pretax Margin | 13.75% | 13.53% | 22.20% | 24.50% | 21.75% | 17.70% |
Profit Margin | 11.59% | 11.30% | 18.38% | 20.40% | 17.45% | 14.66% |
FCF Margin | - | 11.86% | 2.98% | 7.56% | 8.24% | 9.82% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.080 | 0.080 | 0.175 | 0.170 | 0.140 | 0.120 |
Dividend Per Share Growth | -54.29% | -54.29% | 2.94% | 21.43% | 16.67% | 20.00% |
Dividend Yield | 3.25% | 2.86% | 5.21% | 3.82% | 3.73% | 3.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.15 | 17.47 | 9.95 | 11.12 | 11.41 | 15.34 |
Forward PE | 13.23 | 11.38 | 7.50 | 9.55 | 9.51 | 10.52 |
P/FCF Ratio | - | 16.64 | 61.32 | 30.00 | 24.15 | 22.91 |
PS Ratio | 1.75 | 1.97 | 1.83 | 2.27 | 1.99 | 2.25 |